Köln
Germany
14
2023-12-14
The entities that hold a legal rights for patent applications filed by inventor MÄRSCH Stephan:
Stephan MÄRSCH from Köln, DE has applied for patents for these inventions. The list has both pending applications and granted patents:
SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND ANTI-CD123-ANTIBODIES
#2 | 2023-10-26ANTIBODY DRUG CONJUGATES (ADCS) HAVING ENZYMATICALLY CLEAVABLE GROUPS
#3 | 2022-11-17SPECIFIC ANTIBODY DRUG CONJUGATES (ADCS) HAVING KSP INHIBITORS
#4 | 2022-08-25Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodies
#5 | 2022-01-20Antibody drug conjugates (ADCS) having enzymatically cleavable groups
#6 | 2021-09-09BINDER/ACTIVE AGENT CONJUGATES DIRECTED AGAINST CXCR5, HAVING ENZYMATICALLY CLEAVABLE LINKERS AND IMPROVED ACTIVITY PROFILE
#7 | 2021-07-29SPECIFIC ANTIBODY-DRUG-CONJUGATES (ADCS) WITH KSP INHIBITORS AND ANTI-CD123-ANTIBODIES
#8 | 2020-05-07Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with antiB7H3-antibodies
#9 | 2019-12-05Specific antibody drug conjugates (ADCs) having KSP inhibitors
#10 | 2019-10-31Specific antibody-drug-conjugates (ADCs) with KSP inhibitors and anti-CD123-antibodies
#11 | 2019-10-31Antibody drug conjugates (ADCs) having enzymatically cleavable groups
#12 | 2018-11-08ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITORS WITH ANTI-TWEAKR-ANTIBODIES
#13 | 2018-11-08Antibody drug conjugates of kinesin spindel protein (KSP) inhibitors with anti-CD123-antibodies
#14 | 2018-07-05ANTIBODY DRUG CONJUGATES OF KINESIN SPINDEL PROTEIN (KSP) INHIBITORS WITH ANTI-B7H3-ANTIBODIES
2232189 ⎘